Organ Care Products Market Research Report and Outlook by 2028

The global market for organ care products is projected to expand significantly, increasing from US$ 98.46 million in 2021 to US$ 272.16 million by 2028. This growth represents a compound annual growth rate (CAGR) of 15.6% over the forecast period from 2021 to 2028.

The rising incidence of organ failures and the growing number of transplant procedures, along with the introduction of new products and approvals, are key factors driving the demand for organ care products. Conversely, the high costs associated with organ transplantation and cultural barriers present challenges to market growth.

Organ care products are specialized medical devices designed to preserve donated organs for extended periods while supplying essential nutrients. These devices ensure that organs remain in optimal condition and are fully functional prior to transplantation. This technology maintains donor organs at appropriate temperatures, often referred to as "heart in a box." It plays a crucial role in monitoring the health of organs such as kidneys, livers, hearts, and lungs, ensuring they are in peak condition for transplantation. Typically, organ care products consist of multiple pump units, thermal units, and transport trolleys.

Globally, there has been a steady rise in the incidence of organ failure, primarily due to chronic health issues like cardiovascular diseases, genetic disorders, and diabetes. According to a report from the Health Resources and Services Administration in 2020, there were 106,247 individuals on the national transplant waiting list in the United States, with a new person being added every 9 minutes. This escalating rate of organ failure has heightened the demand for transplant procedures, thereby propelling the organ care products market. Additionally, there has been a notable increase in organ donations, attributed to heightened public awareness and advancements in healthcare facilities worldwide. The Global Observatory on Donation and Transplantation reported that approximately 129,681 organ transplants were conducted globally in 2020.

Timing, storage, and transportation are critical components of transplant procedures, particularly in cases of circulatory death. The prompt removal, transport, and implantation of organs are essential for improving success rates, necessitating the use of efficient organ care products to safeguard organs until they can be transplanted. Companies like TransMedics and OrganOx Limited have developed advanced systems that enhance organ safety, moving away from traditional organ transport cooler boxes. Thus, the increasing rates of organ failure and the growing number of individuals on waiting lists are expected to further stimulate the demand for organ care products.

The organ care products market is categorized based on the type of organ, including kidneys, livers, hearts, lungs, and others. In 2021, the kidney segment dominated the market share. However, the lungs segment is projected to experience the highest CAGR during the forecast period. The National Kidney Foundation reports that over 80 million people in the U.S. are at significant risk of kidney failure. Patients with kidney disease and those who have undergone transplants are particularly vulnerable to severe complications from COVID-19. In 2020, kidney-related complications from the coronavirus became the leading cause of mortality in the U.S. The rising incidence of kidney failure has resulted in a substantial number of patients awaiting transplants. In 2020, nearly 91,099 individuals required kidney transplants in the U.S., according to the Health Resources & Services Administration. The National Institute of Diabetes and Digestive and Kidney Diseases indicates that around 661,000 Americans suffer from kidney failure, with 193,000 having received kidney transplants. In Germany, 22.8 kidney transplants were performed per million population in 2020. Consequently, various organ care products have been developed to enhance care for patients with kidney failure. For example, XVIVO's Kidney Assist is a specialized device for pressure-controlled, oxygenated, ex vivo perfusion of donor kidneys, while the Kidney Assist Transport allows for hypothermic perfusion of donor kidneys with an oxygenated solution for up to 24 hours.

Moreover, a range of diseases and conditions leading to lung failure, such as chronic obstructive pulmonary disease (COPD), are expected to drive demand for lung transplants. The World Health Organization (WHO) notes that individuals with advanced COPD face a heightened risk of lung failure necessitating transplantation. The International Society of Heart and Lung Transplantation reports a year-on-year increase in lung transplant operations globally. Factors such as unhealthy lifestyle choices, including smoking and alcohol consumption, as well as a lack of physical activity, contribute to long-term organ failure.

Governments have also taken initiatives to promote organ donation awareness and implement mandatory policies to alleviate organ shortages. For instance, in 2017, France enacted a law making organ donation mandatory post-mortem, under a 'presumed consent' framework, which assumes consent for organ donation unless explicitly opposed by the deceased's family.

Key sources referenced in the preparation of this report on the organ care products market include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Diabetes Federation (IDF), the Health Resources and Services Administration, the Global Observatory on Donation and Transplantation, and the Global Burden of Disease (GBD).